Kelden Sciences Retatrutide 30 mg vial on a white background

.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}

Retatrutide 30mg

Name: Retatrutide 30mg
Brand: Kelden Peptides Canada
Price: 180 CAD
Availability: InStock
Rating: 5 (1 reviews)

Rating is 5.0 out of five stars based on 1 review

Price

$180.00

Retatrutide 30mg provides a higher-volume research format of the investigational GLP-1, GIP and glucagon triple-receptor agonist commonly referenced as LY3437943.

The compound is studied because it combines three distinct metabolic receptor pathways within one molecular structure. Research models frequently use Retatrutide to investigate multi-receptor signaling, incretin biology, energy regulation and metabolic pathway interactions.

The 30mg format provides researchers with an intermediate option between the Retatrutide 20mg and Retatrutide 40mg Kelden Peptides Canada formats while maintaining the same compound identity and lyophilized research presentation.

For additional product documentation, researchers can review our current batch testing and lab reports. Our peptide dosage calculator can also be used for research concentration calculations. For laboratory research use only.

Quantity

Research & Product Details

Compound: Retatrutide Also known as: LY3437943 Form: Lyophilized research peptide Strength: 30mg Research category: GLP-1 / GIP / glucagon triple-receptor research peptide Research overview: Retatrutide is an investigational metabolic research peptide with activity across GLP-1, GIP and glucagon receptor systems. This three-pathway design makes it useful for laboratory investigation of combined incretin and glucagon signaling, receptor cross-talk and metabolic pathway interactions. The 30mg format provides an intermediate higher-strength option between 20mg and 40mg presentations, making it easier to select a total research quantity without changing the compound being studied. Documentation: Published laboratory records are listed separately where available. Batch-specific testing and batch numbers can be added to this section once verified.